ABMD - Abiomed, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
8.32B
Enterprise Value 3
7.89B
Trailing P/E
38.48
Forward P/E 1
37.24
PEG Ratio (5 yr expected) 1
1.77
Price/Sales (ttm)
10.15
Price/Book (mrq)
8.41
Enterprise Value/Revenue 3
9.62
Enterprise Value/EBITDA 6
29.75

Trading Information

Stock Price History

Beta (3Y Monthly) 0.37
52-Week Change 3-40.95%
S&P500 52-Week Change 317.82%
52 Week High 3364.31
52 Week Low 3155.02
50-Day Moving Average 3188.73
200-Day Moving Average 3221.54

Share Statistics

Avg Vol (3 month) 3660.83k
Avg Vol (10 day) 31.11M
Shares Outstanding 545.16M
Float 44.21M
% Held by Insiders 14.12%
% Held by Institutions 189.76%
Shares Short (Oct 31, 2019) 43.63M
Short Ratio (Oct 31, 2019) 44.94
Short % of Float (Oct 31, 2019) 49.22%
Short % of Shares Outstanding (Oct 31, 2019) 48.04%
Shares Short (prior month Sep 30, 2019) 42.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Oct 2, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 26.92%
Operating Margin (ttm)30.28%

Management Effectiveness

Return on Assets (ttm)15.44%
Return on Equity (ttm)24.75%

Income Statement

Revenue (ttm)820.28M
Revenue Per Share (ttm)18.16
Quarterly Revenue Growth (yoy)12.80%
Gross Profit (ttm)639.87M
EBITDA 265.22M
Net Income Avi to Common (ttm)220.82M
Diluted EPS (ttm)4.79
Quarterly Earnings Growth (yoy)-73.90%

Balance Sheet

Total Cash (mrq)445.32M
Total Cash Per Share (mrq)9.86
Total Debt (mrq)12.7M
Total Debt/Equity (mrq)1.28
Current Ratio (mrq)5.77
Book Value Per Share (mrq)21.92

Cash Flow Statement

Operating Cash Flow (ttm)283.89M
Levered Free Cash Flow (ttm)159.59M